Hepatocellular Carcinoma Resectable
9 clinical trials · Condition
◉ Watch Hepatocellular Carcinoma Resectable
| Record | Firm | Date |
|---|---|---|
| A Neoadjuvant Hepatocellular Carcinoma Study of Camrelizumab in Combination With Apatinib and Oxaliplatin (NCT04850040) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2021-05-06 |
| Hypermethylation of VTRNA2-1 Promoter in HCC Outcome (NCT04177316) | Chang Gung Memorial Hospital | 2018-12-01 |
| Predicting Survival After Surgical Resection for the Entire Spectrum of Anatomically Resectable HCC (NCT06294808) | National Cancer Centre, Singapore | 2017-07-17 |
Track Hepatocellular Carcinoma Resectable automatically
Every clearance here is in the API, with alerts when new ones post.